ampelopsin has been researched along with paclitaxel in 1 studies
Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
377 | 2 | 343 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, HF; Chen, M; He, C; Lin, Z; Lu, H; Wang, S; Xu, Y | 1 |
1 other study(ies) available for ampelopsin and paclitaxel
Article | Year |
---|---|
Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Shape; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Female; Flavonols; Humans; Inhibitor of Apoptosis Proteins; Ovarian Neoplasms; Paclitaxel; S Phase; Signal Transduction; Survivin; Tumor Suppressor Protein p53 | 2017 |